Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT05133700

Use and Opinions of Care Home Medicines Audit Tools

Use and Opinions' Concerning Medicines Related Errors, Monitoring and Audit Tools Used to Assess Medicines Optimisation Within Care Homes in England

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
152 (estimated)
Sponsor
University of Central Lancashire · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

To describe the barriers and facilitators experienced by residents, health and social care staff, commissioners and regulators when managing medicines within care homes.

Detailed description

The prescribing of medicines is the most frequent health intervention in England. The administration or omission of medicines is not without risk and incidents involving medicines occur. The frequency of prescribing medicines increases with age and frailty. People living in care homes (with and without nursing) are generally older and more frail than similar groups in the community. Therefore, care homes and their staff need to be proficient and safe when administering medicines. However, an under investigated area of prescribed medicines is the views of people living in care homes, health and social care staff, commissioners and regulator about managing medicines in care homes. During the study a series of semi-structured interviews and focus groups will be undertaken. These focus groups will be held with people living in care homes (with and without nursing). Further interviews and focus groups will be held with health and social care staff, commissioners and regulators. Care homes will be invited to provide copies of their current medicines monitoring tool. In addition, services supporting care homes including community pharmacies will also be invited to provide copies of their current medicines monitoring tools. Analysis of conversations and monitoring tools made available to the study team will be undertaken and compared to published literature including grey literature.

Conditions

Interventions

TypeNameDescription
OTHERInterview or focus group discussionThere is no intervention. This is a qualitative piece of work only
OTHERReview of submitted medicines audit toolsThere is no intervention. This is a qualitative piece of work only

Timeline

Start date
2022-03-23
Primary completion
2025-01-19
Completion
2025-12-31
First posted
2021-11-24
Last updated
2025-01-23

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05133700. Inclusion in this directory is not an endorsement.